Arteriogenesis is associated with an induction of the cardiac ankyrin repeat protein (carp)

Cardiovascular Research

Volumn 59, Issue 3, 2003, Pages 573-581

  Boengler, Kerstin ^a   Pipp, Frederic ^a   Fernandez, Borja ^a   Ziegelhoeffer, Tibor ^a   Schaper, Wolfgang ^a   Deindl, Elisabeth ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Arteries; Collateral circulation; Cytokines; Gene expression; Remodeling

Indexed keywords

CANCER GROWTH FACTOR; CARDIAC ANKYRIN REPEAT PROTEIN; COMPLEMENTARY DNA; DOXORUBICIN; EARLY GROWTH RESPONSE FACTOR 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; ASSOCIATION; BLOOD PUMP; CELL ISOLATION; CELL LINE; COLLATERAL CIRCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; FEMORAL ARTERY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; IN SITU HYBRIDIZATION; IN VIVO STUDY; INFUSION; INTERMETHOD COMPARISON; MOUSE; NEW ZEALAND; NONHUMAN; NORTHERN BLOTTING; OSMOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN INDUCTION; RABBIT; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ARTERIES; BLOTTING, WESTERN; CHEMOKINE CCL2; COLLATERAL CIRCULATION; COS CELLS; DNA-BINDING PROTEINS; DOXORUBICIN; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION; IMMEDIATE-EARLY PROTEINS; IN SITU HYBRIDIZATION; MODELS, ANIMAL; MUSCLE PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; RABBITS; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 1642407162     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00511-X     Document Type: Article

References (43)

1. Ito W.D., Arras M., Scholz D., et al. Angiogenesis but not collateral artery growth is associated with ischemia after femoral artery occlusion. Am J Physiol. 273:1997;H1255-H1265.
2. Scholz D., Ziegelhoeffer T., Helisch A., et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol. 34:2002;775-787.
3. Deindl E., Buschmann I., Hoefer I.E., et al. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res. 89:2001;779-786.
4. Khachigian L.M., Anderson K.R., Halnon N.J., et al. Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter. Arterioscler Thromb Vasc Biol. 17:1997;2280-2286.
5. Houston P., White B.P., Campbell C.J., Braddock M. Delivery and expression of fluid shear stress-inducible promoters to the vessel wall: Applications for cardiovascular gene therapy. Hum Gene Ther. 10:1999;3031-3034.
6. Khachigian L.M., Collins T. Early growth response factor 1: a pleiotropic mediator of inducible gene expression. J Mol Med. 76:1998;613-616.
7. Arras M., Ito W.D., Scholz D., et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 101:1998;41-50.
8. Hoefer I.E., van Royen N., Buschmann I.R., Piek J.J., Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res. 49:2001;609-617.
9. Buschmann I.R., Hoefer I.E., van Royen N., et al. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis. 159:2001;343-356.
10. van Royen N., Hoefer I., Buschmann I., et al. Exogenous application of transforming growth factor � 1 stimulates arteriogenesis in the peripheral circulation. FASEB J. 3:2002;432-434.
11. Scholz D., Ito W., Fleming I., et al. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch. 436:2000;257-270.
12. Diatchenko L., Lau Y.-F., Campbell A.P., et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA. 93:1996;6025-6030.
13. Ito W.D., Arras M., Winkler B., et al. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 80:1997;829-837.
14. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
15. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 2nd edition:1989;Cold Spring Harbor, Cold Spring Harbor Laboratory Press, NY.
16. Deindl E. 18S ribosomal RNA detection on Northern blot employing a specific oligonucleotide. BioTechniques 2001;31:1250, 1252.
17. Barancik M., Htun P., Strohm C., Kilian S., Schaper W. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol. 35:2000;474-483.
18. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucl Acids Res. 17:1989;6419.
19. Aihara Y., Kurabayashi M., Arai M., Kedes L., Nagai R. Molecular cloning of rabbit CARP cDNA and its regulated expression in adriamycin-cardiomyopathy. Biochem Biophys Acta. 1447:1999;318-324.
20. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biol Sci. 21:1996;267-271.
21. Sedgwick S.G., Smerdon S.J. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem Sci. 24:1999;311-316.
22. Zou Y., Evans S., Chen J., et al. A cardiac ankyrin repeat protein, is downstream in the NKX2-5 homeobox gene pathway. Development. 124:1997;793-804.
23. Baumeister A., Arber S., Caroni P. Accumulation of muscle ankyrin repeat protein transcript reveals local activity of primary myotube endcompartments during muscle morphogenesis. J Cell Biol. 139:1997;1231-1242.
24. Chu W., Burns D.K., Swerlick R.A., Presky D.H. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J Biol Chem. 270:1995;10236-10245.
25. Kanai H., Tanaka T., Aihara Y., et al. Transforming growth factor-(�)/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Circ Res. 88:2001;30-39.
26. Kuo H.C., Chen J., Ruiz-Lozano P., et al. Control of segmental expression of the cardiac-restricted ankyrin repeat protein gene by distinct regulatory pathways in murine cardiogenesis. Development. 126:1999;4223-4234.
27. Aihara Y., Kurabayashi K., Saito Y., et al. Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy. Hypertension. 36:2000;48-53.
28. Zolk O., Frohme M., Maurer A., et al. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun. 293:2002;1377-1382.
29. Neyses L., Pelzer T. The biological cascade leading to cardiac hypertrophy. Eur Heart J. 16:(Suppl N):1995;8-11.
30. Yamazaki T., Komuro I., Yazaki Y. Molecular mechanism of cardiac hypertrophy by mechanical stress. J Mol Cell Cardiol. 27:1995;133-140.
31. Tsai J.C., Liu L., Cooley B.C., et al. The Egr-1 promoter contains information for constitutive and inducible expression in transgenic mice. FASEB J. 14:2000;1870-1872.
32. Jeyaseelan R., Poizat C., Baker R.K., et al. A novel cardiac-restricted target for doxorubicin. J Biol Chem. 272:1997;22800-22808.
33. Yoshisue H., Suzuki K., Kawabata A., et al. Large scale isolation of non-uniform shear stress-responsive genes from cultured endothelial cells through the preparation of a subtracted library. Atherosclerosis. 162:2002;323-334.
34. Schwachtgen J.-L., Houston P., Campbell C., Sukhatme V., Braddock M. Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells Is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway. J Clin Invest. 101:1998;2540-2549.
35. Liu C., Jao J., de Belle I., et al. The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-� 1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem. 274:1999;4400-4411.
36. Biesiada E., Razandi M., Levin E.R. Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation. J Biol Chem. 271:1996;18576-18581.
37. Deindl E., Fernandez B., Ziegelhoeffer T., Schaper W. Collateral artery growth is associated with an increased expression of egr-1. FASEB J. 15:2001;798.7.
38. Doukas J., Blease K., Craig D., et al. Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. Mol Ther. 5:2002;517-527.
39. Yang H.T., Deschenes M.R., Ogilvie R.W., Terjung R.L. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res. 79:1996;62-69.
40. Khachigian L.M., Lindner V., Williams A.J., Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science. 271:1996;1427-1431.
41. Deindl E., Ziegelhoffer T., Kanse S.M., et al. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis. FASEB J. 17:2003;1174-1176.
42. Pepper M.S. Transforming growth factor-�: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8:1997;21-43.
43. Aihara Y., Kurubayashi M., Tanako T., et al. Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/threonine kinase-dependent pathways. J Mol Cell Cardiol. 32:2000;1401-1414.